Tellgen Corp - Asset Resilience Ratio

Latest as of March 2026: 9.96%

Tellgen Corp (300642) has an Asset Resilience Ratio of 9.96% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300642 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥200.66 Million
≈ $29.36 Million USD Cash + Short-term Investments

Total Assets

CN¥2.01 Billion
≈ $294.79 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Tellgen Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300642 asset base.

Liquid Assets Composition Over Time

This chart breaks down Tellgen Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Tellgen Corp debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥200.66 Million 9.96%
Total Liquid Assets CN¥200.66 Million 9.96%

Asset Resilience Insights

  • Limited Liquidity: Tellgen Corp maintains only 9.96% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Tellgen Corp Industry Peers by Asset Resilience Ratio

Compare Tellgen Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Stratec SE
XETRA:SBS
Medical Devices 0.29%
Shinhung
KO:004080
Medical Devices 4.17%
DRTECH Corporation
KQ:214680
Medical Devices 5.18%
Novacyt
PA:ALNOV
Medical Devices 0.02%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%

Annual Asset Resilience Ratio for Tellgen Corp (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Tellgen Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 8.29% CN¥170.57 Million
≈ $24.96 Million
CN¥2.06 Billion
≈ $300.98 Million
-2.10pp
2024-12-31 10.39% CN¥181.75 Million
≈ $26.60 Million
CN¥1.75 Billion
≈ $255.93 Million
+4.26pp
2023-12-31 6.13% CN¥103.02 Million
≈ $15.07 Million
CN¥1.68 Billion
≈ $245.80 Million
-9.54pp
2022-12-31 15.67% CN¥260.88 Million
≈ $38.17 Million
CN¥1.66 Billion
≈ $243.60 Million
-2.43pp
2021-12-31 18.10% CN¥271.35 Million
≈ $39.71 Million
CN¥1.50 Billion
≈ $219.33 Million
+0.33pp
2020-12-31 17.77% CN¥243.77 Million
≈ $35.67 Million
CN¥1.37 Billion
≈ $200.73 Million
-5.62pp
2019-12-31 23.39% CN¥291.60 Million
≈ $42.67 Million
CN¥1.25 Billion
≈ $182.40 Million
+23.89pp
2018-12-31 -0.50% CN¥-5.47 Million
≈ $-800.28K
CN¥1.10 Billion
≈ $161.38 Million
+0.18pp
2017-12-31 -0.68% CN¥-6.37 Million
≈ $-931.69K
CN¥935.16 Million
≈ $136.84 Million
--
pp = percentage points

About Tellgen Corp

SHE:300642 China Medical Devices
Market Cap
$402.72 Million
CN¥2.75 Billion CNY
Market Cap Rank
#13483 Global
#4033 in China
Share Price
CN¥16.96
Change (1 day)
+1.62%
52-Week Range
CN¥11.22 - CN¥28.18
All Time High
CN¥46.24
About

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more